ELYM Old Financials

ELYMDelisted Stock  USD 3.09  0.06  1.90%   
Based on the measurements of operating efficiency obtained from ELYM Old's historical financial statements, ELYM Old is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.
  
Understanding current and past ELYM Old Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ELYM Old's financial statements are interrelated, with each one affecting the others. For example, an increase in ELYM Old's assets may result in an increase in income on the income statement.

ELYM Old Stock Summary

ELYM Old competes with Pmv Pharmaceuticals, MediciNova, Pharvaris, PepGen, and Anebulo Pharmaceuticals. Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington. Eliem Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business AddressPMB 117, 2801
New SymbolCLYM
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websiteeliemtx.com
Phone877 354 3689
CurrencyUSD - US Dollar

ELYM Old Key Financial Ratios

ELYM Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ELYM Old's current stock value. Our valuation model uses many indicators to compare ELYM Old value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ELYM Old competition to find correlations between indicators driving ELYM Old's intrinsic value. More Info.
ELYM Old is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value ELYM Old by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

ELYM Old Market Pulse

 Quote3.09
 Change(%)  1.90 
 Change0.06 
 Open3.15
 Low3.07
 High3.19
 Volume0
 ExchangeNASDAQ

ELYM Old January 22, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of ELYM Old help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ELYM Old. We use our internally-developed statistical techniques to arrive at the intrinsic value of ELYM Old based on widely used predictive technical indicators. In general, we focus on analyzing ELYM Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ELYM Old's daily price indicators and compare them against related drivers.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Consideration for investing in ELYM Stock

If you are still planning to invest in ELYM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ELYM Old's history and understand the potential risks before investing.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine